DK1694641T3 - Prostaglandinsyntese - Google Patents

Prostaglandinsyntese

Info

Publication number
DK1694641T3
DK1694641T3 DK04801246T DK04801246T DK1694641T3 DK 1694641 T3 DK1694641 T3 DK 1694641T3 DK 04801246 T DK04801246 T DK 04801246T DK 04801246 T DK04801246 T DK 04801246T DK 1694641 T3 DK1694641 T3 DK 1694641T3
Authority
DK
Denmark
Prior art keywords
alkyl
group
prostaglandin synthesis
halo
formula
Prior art date
Application number
DK04801246T
Other languages
Danish (da)
English (en)
Inventor
Derek Wyndham Clissold
Stuart Wilbert Craig
Rajendrakumar Reddy Gadikota
Min He
Jurjus Fayez Jurayj
Shahrokh Kazerani
Erwin Rannala
Pradeep Kumar Sharma
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Application granted granted Critical
Publication of DK1694641T3 publication Critical patent/DK1694641T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK04801246T 2003-12-19 2004-12-01 Prostaglandinsyntese DK1694641T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0329379.2A GB0329379D0 (en) 2003-12-19 2003-12-19 Prostaglandin synthesis
PCT/GB2004/005028 WO2005058812A2 (fr) 2003-12-19 2004-12-01 Synthese de la prostaglandine

Publications (1)

Publication Number Publication Date
DK1694641T3 true DK1694641T3 (da) 2009-07-20

Family

ID=30471335

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04801246T DK1694641T3 (da) 2003-12-19 2004-12-01 Prostaglandinsyntese

Country Status (14)

Country Link
EP (1) EP1694641B1 (fr)
JP (3) JP4764828B2 (fr)
KR (1) KR20060118555A (fr)
CN (2) CN1894209B (fr)
AT (1) ATE428693T1 (fr)
AU (2) AU2004299316B2 (fr)
CA (2) CA2549056C (fr)
CZ (1) CZ305964B6 (fr)
DE (1) DE602004020667D1 (fr)
DK (1) DK1694641T3 (fr)
ES (1) ES2325266T3 (fr)
GB (1) GB0329379D0 (fr)
IL (2) IL175940A (fr)
WO (1) WO2005058812A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008037782A (ja) * 2006-08-04 2008-02-21 Daiichi Fine Chemical Co Ltd プロスタグランジン誘導体の製造方法
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative
AR071312A1 (es) * 2008-04-09 2010-06-09 Scinopharm Taiwan Ltd Proceso para la preparacion de analogos de prostaglandina y sus intermediarios
EP2135860A1 (fr) * 2008-06-20 2009-12-23 Sandoz AG Procédé amélioré pour la production de Bimatoprost
WO2011008756A1 (fr) 2009-07-13 2011-01-20 Irix Pharmaceuticals Synthèse de prostanoïdes
CN102050772B (zh) * 2009-11-02 2013-08-21 上海天伟生物制药有限公司 一种比马前列素晶体及其制备方法和用途
US9238621B2 (en) * 2011-06-02 2016-01-19 Chinoin Zrt Processes for the preparation of prostaglandin amides
HU231203B1 (hu) * 2011-12-21 2021-10-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
WO2013133730A1 (fr) * 2012-03-09 2013-09-12 Instytut Farmaceutyczny Procédé de préparation d'analogues de prostaglandine f2α
EP2911623B1 (fr) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Système ophtalmique pour la libération prolongée de médicament dans l' oeil
US10100028B2 (en) 2013-09-30 2018-10-16 Patheon Api Services Inc. Synthesis routes for prostaglandins and prostaglandin intermediates using metathesis
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
EP3235810A1 (fr) 2016-04-19 2017-10-25 Gentec, S.A. Procédé pour la préparation de bimatoprost

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582853A (en) * 1977-06-16 1981-01-14 Ici Ltd Prostane derivatives
JPS562979A (en) * 1979-06-19 1981-01-13 Ono Pharmaceut Co Ltd Prostaglandin i2 analog compound, its preparation, and pharmaceutical composition containing the same
JPS57171965A (en) * 1981-04-15 1982-10-22 Teijin Ltd Novel prostaglandin intermediate and its preparation
US4708966A (en) * 1986-06-27 1987-11-24 The Procter & Gamble Company Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
JPS63188687A (ja) * 1987-01-30 1988-08-04 Sagami Chem Res Center 有機ケイ素化合物の製造方法
JP2536026B2 (ja) * 1988-03-10 1996-09-18 史衛 佐藤 α,β―置換シクロペンタノン誘導体の製造法
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
US6015922A (en) * 1997-12-19 2000-01-18 Alcon Laboratories, Inc. N-alkyl-N-alkoxycarboxamides and methods of use in prostaglandin synthesis
GB9908327D0 (en) * 1999-04-12 1999-06-09 Chirotech Technology Ltd Process for the preparation of prostaglandin precursors
AU770343B2 (en) * 1999-09-06 2004-02-19 Fumie Sato Prostaglandin E analogues
WO2003008368A1 (fr) * 2001-07-17 2003-01-30 Pharmacia & Upjohn Company Procede et produits intermediaires utilises pour produire du latanoprost
US20030187071A1 (en) * 2001-07-17 2003-10-02 Henegar Kevin E. Process and intermediates to prepare latanoprost

Also Published As

Publication number Publication date
JP2011201883A (ja) 2011-10-13
JP2007517780A (ja) 2007-07-05
KR20060118555A (ko) 2006-11-23
WO2005058812A2 (fr) 2005-06-30
JP5795354B2 (ja) 2015-10-14
CA2549056A1 (fr) 2005-06-30
ATE428693T1 (de) 2009-05-15
ES2325266T3 (es) 2009-08-31
CN1894209A (zh) 2007-01-10
CA2854783C (fr) 2017-01-10
IL217670A (en) 2013-02-28
CA2854783A1 (fr) 2005-06-30
CN101486699B (zh) 2012-06-27
JP5653827B2 (ja) 2015-01-14
IL175940A0 (en) 2006-10-05
CA2549056C (fr) 2014-09-02
AU2011200763B2 (en) 2013-05-30
CZ305964B6 (cs) 2016-05-25
JP4764828B2 (ja) 2011-09-07
CZ2006386A3 (cs) 2006-11-15
DE602004020667D1 (en) 2009-05-28
AU2011200763A1 (en) 2011-03-17
AU2004299316B2 (en) 2011-01-06
EP1694641A2 (fr) 2006-08-30
WO2005058812A3 (fr) 2005-10-13
IL175940A (en) 2012-05-31
EP1694641B1 (fr) 2009-04-15
GB0329379D0 (en) 2004-01-21
JP2013231053A (ja) 2013-11-14
AU2004299316A1 (en) 2005-06-30
CN1894209B (zh) 2010-12-22
CN101486699A (zh) 2009-07-22

Similar Documents

Publication Publication Date Title
IL175940A0 (en) Prostaglandin synthesis
CY1112011T1 (el) Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
HUP0402507A2 (hu) N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények
DK1451155T3 (da) Sammensætninger, metoder og kits i forbindelse med luminescerende forbindelser
RS51136B (sr) Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba
EA200800886A1 (ru) Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов
HUP0303241A2 (hu) Pirazolil-pirimidin-származékok, előállításuk, alkalmazásuk és az előállításukhoz használt köztitermékek
PT806416E (pt) Derivados de huperzina a sua preparacao e utilizacao
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
NO20060643L (no) Nye metoder for fremstilling av 2H-kromener
DE69529619T2 (de) Pyrimidinylpyrazolderivate
HUP0201357A2 (hu) Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával
EA200700767A1 (ru) Способ получения пиразолов
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
MEP18708A (en) Process for the production of beraprost and its salts
EP1637526A4 (fr) Composes polycycliques durcissables et leur procede de production
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
NZ335105A (en) Process for alkylating hindered sulfonamides
EA200401077A1 (ru) 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
KR840005449A (ko) 벤조티오 피라노 피리디논
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
MY151167A (en) Benzimidazole compound
HUP0303686A2 (hu) Eljárás Delta1-pirrolin-származékok előállítására és az új intermedierek
IS6636A (is) Hringlaga ketonar og notkun þeirra í smíði amínósýra